HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antidepressant drugs in cancer patients: the case of escitalopram.

AuthorsLamprini Tsali, Magdalini Bristianou, Antonis Valachis, Davide Mauri, Nikolaos Barotsis, Evangelia Bellou
JournalThe journal of supportive oncology (J Support Oncol) 2009 Jul-Aug Vol. 7 Issue 4 Pg. 119 ISSN: 1544-6794 [Print] United States
PMID19731573 (Publication Type: Case Reports, Letter)
Chemical References
  • Antidepressive Agents, Second-Generation
  • Serotonin Uptake Inhibitors
  • Citalopram
Topics
  • Aged
  • Antidepressive Agents, Second-Generation (adverse effects)
  • Brain Neoplasms (complications, therapy)
  • Citalopram (adverse effects)
  • Female
  • Glioblastoma (complications, therapy)
  • Humans
  • Hyponatremia (chemically induced)
  • Inappropriate ADH Syndrome (chemically induced)
  • Selective Serotonin Reuptake Inhibitors (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: